Sleep apnoea and oxygen therapy. Flashcards

(29 cards)

1
Q

Sources of oxygen

A

Oxygen cylinder

Wall supply

Oxygen concentrators

Liquid oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Oxygen cylinders

A

Supplies 100%.

Comes in various sizes and only gives O2 for a limited length of time.

Used for treatments that last for a short duration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Wall supply of O2

A

Only available in the hospital

Supplies 100%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Oxygen concentrators

A

Machine that has a molecular sleeve to remove nitrogen.

Concentration >90%.

Mobile use of oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Liquid oxygen

A

Highly compressed oxygen that allows larger volume of O2.

Not in the UK.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Nasal cannulae

A

Delivers O2- 24-40%.

Flow rate: 1-4L/min

Uses: mild hypoxaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indication for nasal cannulae

A

Mild hypoxaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Uncontrolled re-breathe masks

  • Example
  • Concentration
  • Flow
A

Example- Hudson mask.

Delivers 30-60%

Flow rate: 5-10L/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Uncontrolled non-rebreathe masks

  • Concentration
  • Flow rate
  • Indication
A

85-90%

15L/min

Indication- acutely unwell patients.

One way valve prevents room air mixing with O2 supplied.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Venturi masks

A

Supplies a fixed concentration of O2.

Blue- 24%, 2-4L
White- 28% 4-6L
Yellow- 35% 8-10L
Red- 40% 10-12 L
Green- 60% 12-15L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Oxygen concentrations supplied by venturi

A

24% (blue)

28% (white)

35% (yellow)

40% (red)

60% (green)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

4 main clinical indications for O2

A
  1. Acutely hypoxaemic patients.
  2. Chronically hypoxaemic with acute exacerbation.
  3. Chronically hypoxaemic who are stable.
  4. Palliative use in cancer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

O2 sat targets in those at risk of hypercapnic patients

A

88-92%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

O2 target for normal adults and most patients

A

Normal:

96-98%

Patients- 94-98%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute hypoxaemia examples

A

Acute pulmonary oedema.

Acute pneumonia

Acute pneumothorax

Acute asthma

MI

Sepsis

CO poisoning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute breathlessness with hypoxaemia

  • Risk
  • O2 Treatment
  • Non-O2 treatment
A

Risk: acute cardiac arrhythmia and organ failure.

Treatment:
Max O2- high uncontrolled.
Target SpO2- 94-98%

Non-O2:

  • Secure airway patency
  • Avoid respiratory depressants
  • Treat established reason for hypoxaemia
  • Possible ventilation (IPPV)
17
Q

Chronically hypoxaemic with COPD + acute exacerbation.

  • Example of exacerbation.
  • Treatment
A

Example:
Bacterial infection
Heart failure episode

Treatment:

  • Fixed O2, venturi 24%
  • Target SpO2 at 88-92%
  • pH kept >7.35
18
Q

Chronically hypoxaemic with COPD + acute exacerbation.

  • Example of exacerbation.
  • Treatment
A

Example:
Bacterial infection
Heart failure episode

Treatment:

  • Fixed O2, venturi 24%
  • Target SpO2 at 88-92%
  • pH kept >7.35
  • CO2<6
  • pO2 <10
19
Q

Chronically hypoxaemic patients that are stable:

  • Problems if not treated
  • O2 therapy
A

Used in COPD and some bronchiectasis.

Problems caused if not treated:

  • Pulmonary artery hypertension.
  • RV hypertrophy
  • Cor pulmonale.

O2:
LTOT

20
Q

LTOT

A

Long term O2 treatment.

Given to some patients with stable COPD.

21
Q

Areas of the pharynx

A

Nasopharynx

Oropharynx

Laryngopharynx

22
Q

What happens to the pharynx during sleep apnoea

A

The tendency of the pharynx to collapse increases due to the following factors:

  • Decrease in the neuromuscular tone of the upper airway (UA).
  • Decrease in the caliber of the UA.
  • Increase in resistance of the UA.
  • Increase in pharyngeal compliance
23
Q

Sleep apnoea cycle

A
  1. Sleep.
  2. Relaxation of the muscles and tissues surrounding the pharyngeal airway.
  3. Collapse and obstruction of the airway= snoring.
  4. Apnoea
  5. Arousal
  6. Return of muscular tone
  7. Resumption of breathing.
24
Q

CPAP

A

Continuous positive airway pressure

Used to treat sleep apnoea.

The device generates airflow by delivering positive pressure via a mask.

Keeps the pharynx open by making the intraluminal pharyngeal pressure> surrounding pressure.

25
Benefits of CPAP
Resolves symptoms Decreases : - Apnoea - Daytime sleepiness - Risk of road accidents. Increases quality of life
26
Problems of CPAP
Mask problems: leaks and discomfort. Life long Can cause airway drying and irritation. Difficult to adhere to
27
Behavioural changes to manage sleep apnoea
Weight loss Avoid sleeping supine Avoiding alcohol
28
Mandibular advancement devices
Equipment used to treat sleep apnoea. Holds the soft tissue of the oropharynx forward. Used for mild-moderate sleep apnoea.
29
Consequences of obstructive sleep apnoea
Increased risk of road accidents. ``` Associated with many conditions: T2 diabetes Hypertension IHD Heart failure Stroke Arrythmias Death ```